• Publications
  • Influence
FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States.
TLDR
It is estimated that there were 1.4 million nontyphoidal Salmonella infections in the United States, resulting in 168,000 physician office visits per year during 1996-1999 and that salmonellosis presents a major ongoing burden to public health. Expand
Burden of Clostridium difficile infection in the United States.
TLDR
C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011, and the North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community- associated infections. Expand
Methicillin-resistant Staphylococcus aureus disease in three communities.
TLDR
Community-associated MRSA infections are now a common and serious problem, especially among children, and hospitalization is common. Expand
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
TLDR
Dramatic reductions in IPD after PCV7 introduction in the United States remain evident 7 years later, and IPD rates caused by serotype 19A and other non-PCV7 types have increased but remain low relative to decreases in PCV 7-type IPD. Expand
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
TLDR
Over a six-year period, there has been a substantial decline in the incidence of group B streptococcal disease in newborns, including a major reduction in the excess incidence of these infections in black infants. Expand
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
TLDR
The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults. Expand
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.
TLDR
Among infants from birth through 6 days, the incidence of group B streptococcal disease was lower in 2003-2005 relative to 1999-2001, and this reduction coincided with the release of revised disease prevention guidelines in 2002. Expand
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
TLDR
The incidence of pneumococcal disease caused by nonvaccine serotypes is increasing and Ongoing surveillance is needed to monitor the magnitude of disease cause by non vaccines, to ensure that future vaccines target the appropriate serotypes. Expand
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.
TLDR
PCV13 reduced IPD across all age groups when used routinely in children in the USA, providing reassurance that, similar to PCV7, PCVs with additional serotypes can also prevent transmission to unvaccinated populations. Expand
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.
TLDR
Invasive GBS disease in nonpregnant adults represents a substantial and increasing burden, particularly among older persons, black persons, and adults with diabetes, and prevention strategies are needed. Expand
...
1
2
3
4
5
...